No Data
Catalyst Watch: FOMC, FedEx Earnings, Electronic Arts Event, and Triple Witching Day
William Blair Initiates Zevra Therapeutics(ZVRA.US) With Buy Rating
William Blair Keeps Their Buy Rating on Zevra Therapeutics (ZVRA)
Zevra Therapeutics Presented New Data for Arimoclomol and OLPRUVA (Sodium Phenylbutyrate) at the Society for the Study of Inborn Errors of Metabolism (SSIEM) 2024 Annual Symposium
Zevra Therapeutics to Participate at Upcoming Investor Conferences
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session